ArticleEuropean urology2020

Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

Guillaume PloussardPubMed ↗Publisher ↗

No numbers read from the abstract.